Strategic Forecast for the Urinary Incontinence Industry: Market Outlook 2025-2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Urinary Incontinence Market Size Growth Forecast: What to Expect by 2025?
The market for urinary incontinence has experienced a significant surge in recent years. The market size is projected to increase from $12.52 billion in 2024 to $13.37 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. This growth during the historic period has been influenced by factors such as an aging population, increased awareness about urinary incontinence, a growing incidence of the condition, improved access to healthcare, and higher disposable incomes.

How Will the Urinary Incontinence Market Size Evolve and Grow by 2029?
The market for urinary incontinence is projected to exhibit robust expansion in the coming years. It is estimated to reach a worth of $17.39 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%. The future growth of this market can be credited to a rise in associated conditions, lifestyle influences, public health initiatives, as well as growing healthcare expenses. Key trends to look out in the forecast period encompass advancement in medicine, innovative technology, non-invasive medical procedures, digital health and mobile health platforms, inventive product designs, and patient-focused care.

View the full report here:
https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report

What Drivers Are Propelling the Growth of Urinary Incontinence Market Forward?
The urinary incontinence market is set to witness a surge due to the increasing incidence of urological disorders. These disorders, typically affecting the urinary system and male reproductive organs, include kidneys, bladder, ureters, urethra, and male organs like the prostate and testes. With the rise in conditions like urinary incontinence, the demand for corresponding treatments and products is mounting. This growth is further hastened by enhancements in medical awareness, healthcare infrastructure, and emerging innovative solutions. The American Cancer Society Inc's report in January 2023 revealed an increase of 1.1% in estimated urinary bladder cancer cases in the United States, going up from 81,400 in 2020 to 82,290 in 2023. This amplification in the incidence of urological disorders is projected to spur the urinary incontinence market's growth. The urinary incontinence market is also poised to benefit from the escalating demand for minimally invasive procedures. These surgical techniques make use of advanced tools and technology to minimize physical incisions in patients. As a favorable, patient-centric treatment for urinary incontinence, minimal invasive operations are gaining popularity among patients and healthcare professionals. They help alleviate the condition with least interference in the patient's daily routine and overall health. Evidently, in 2022, around 1,875,000 surgical procedures were executed using Intuitive Surgical Inc's Vinci surgical systems. The number marked an 18% hike from about 1,594,000 procedures performed in 2021 using the same system. Consequently, the surging demand for minimally invasive procedures underscores the projected growth trajectory of the urinary incontinence market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12946&type=smp

Which Emerging Trends Are Transforming the Urinary Incontinence Market in 2025?
Top corporations in the urinary incontinence market are actively adopting cutting-edge technologies and innovative methods to improve patient care and treatment results. For example, UroMems SAS, a biotech firm based in France, successfully implanted the UroActive smart, automatic artificial urinary sphincter (AUS) in a female patient to address stress urinary incontinence (SUI) in women in July 2023. The UroActive device, a breakthrough product, uses a myoelectrical mechanical system (MEMS) to provide a definitive solution for women's SUI. The operation, conducted with robot-assisted precision at La Pitié-Salpêtrière University Hospital in Paris, received regulatory approval from the French equivalent of the FDA. The UroActive device offers adjustability and intelligent features, coupled with a minimally invasive technique, aiming to enhance a patient's quality of life.

What Are the Key Segments in the Urinary Incontinence Market?
The urinary incontinence market covered in this report is segmented -

1) By Type: Urge Incontinence, Stress Incontinence, Overflow Incontinence, Functional Incontinence
2) By Treatment Type: Medication, Devices, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By Diagnosis: Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Urge Incontinence: Overactive Bladder, Urinary Urgency
2) By Stress Incontinence: Involuntary Leakage During Physical Activity, Coughing Or Sneezing
3) By Overflow Incontinence: Chronic Urinary Retention, Frequent Or Constant Dribbling
4) By Functional Incontinence: Cognitive Impairment, Physical Limitations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12946&type=smp

Who Are the Key Players Shaping the Urinary Incontinence Market's Competitive Landscape?
Major companies operating in the urinary incontinence market are Cardinal Health Inc., Johnson and Johnson, Medtronic PLC, Eli Lilly and Company, Asahi Kasei Corporation, Becton inson and Company (C.R. Bard Inc.), Teva Pharmaceutical Industries Ltd., Berry Global Inc., Boston Scientific Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Domtar Corporation, Cook Medical Inc., Aurobindo Pharma Ltd., Coloplast AIS, Teleflex Incorporated, Apotex Inc., Zydus Lifesciences Limited, ConvaTec Group PLC, Cook Group Inc., Torrent Pharmaceuticals Ltd., Alennbic Pharmaceuticals Limited, Laborie Medical Technologies Corp., NeoTract Inc., Ethicon Inc., Promedon GmbH, Caldera Medical Inc.

What Geographic Markets Are Powering Growth in the Urinary Incontinence Market?
North America was the largest region in the urinary incontinence market in 2024. The regions covered in urinary incontinence market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12946

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.